FDA Inspection 1261592 — Hobart Laboratories, Inc.

Hobart Laboratories, Inc. — FEI 1410004

The FDA completed an inspection of Hobart Laboratories, Inc. on February 7, 2025 in Bemidji, MN. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 7, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Bemidji, MN (United States)